[G-CSF in patients with lupus-associated neutropenia and infections]

Z Rheumatol. 1996 May-Jun;55(3):174-9.
[Article in German]

Abstract

Nine patients with SLE-associated neutropenia and infections received 48 Mio U G-CSF per day s.c. for 2-17 days as an adjunct to antibiotic treatment. Granulopoiesis was normal or hyperplastic in all cases. The mean granulocyte count increased within 2 days from 1.4 per nl to 11.4 per nl. Side-effects were exacerbating CNS symptoms in two patients and a case of leukocytoclastic vasculitis. G-CSF induced constantly a rapid and distinct increase of neutrophil granulocytes in lupus-associated neutropenia patients with normo- or hyperplastic granulopoiesis.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocytes / drug effects
  • Granulocytes / immunology
  • Humans
  • Injections, Subcutaneous
  • Leukocyte Count / drug effects
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / therapy*
  • Male
  • Neutropenia / immunology
  • Neutropenia / therapy*
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Opportunistic Infections / immunology
  • Opportunistic Infections / therapy*

Substances

  • Granulocyte Colony-Stimulating Factor